A nonlinear relationship between dietary inflammatory index and stroke among US adults with metabolic dysfunction-associated steatotic liver disease

被引:1
|
作者
Guo, Renwei [1 ]
Du, Juan [2 ]
机构
[1] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Neurol, Xuzhou 221006, Jiangsu, Peoples R China
关键词
cross-sectional study; dietary inflammatory index; metabolic dysfunction-associated steatotic liver disease; stroke; NATIONAL-HEALTH; RISK;
D O I
10.1097/MEG.0000000000002876
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundSome studies have found that high dietary inflammatory index (DII) increases stroke risk, but previous studies have mostly been conducted in the general population, and the exact relationship between DII and stroke in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is not clear.MethodsThis cross-sectional study utilized data from the National Health and Nutrition Examination Survey (2009-2016) to investigate the association between the DII and stroke. DII was computed according to established methods. Participants were categorized into tertiles of DII (Q1-Q3). Multivariate weighted logistic regression analysis, smooth curve fitting, and subgroup analysis were employed to explore this relationship. Subgroup analyses were conducted based on demographic and clinical variables.ResultsA total of 2426 individuals were enrolled in our study. The overall prevalence of stroke in the study population was 4.66%. The smooth curve fitting analysis indicated a J-shaped relationship between DII and stroke among individuals with MASLD. In multivariate weighted logistic regression analysis, the odds ratio (OR) of DII is 1.17 (95% CI: 1.03-1.38) for stroke, with a turning point of 1.89. After the turning point, the OR (95% CI) was 1.22 (1.08-2.56). In subgroup analysis, DII still increased the risk of stroke independently.ConclusionOur study highlighted a J-shaped association between DII and stroke in adults with MASLD from USA.
引用
收藏
页码:272 / 278
页数:7
相关论文
共 50 条
  • [31] The association between metabolic dysfunction-associated steatotic liver disease diagnosis and vasomotor symptoms in midlife women
    Aldhaleei, Wafa A.
    Kapoor, Ekta
    Shufelt, Chrisandra
    Wallace, Michael B.
    Kling, Juliana M.
    Cole, Kristin
    Winham, Stacey J.
    Hedges, Mary S.
    Faubion, Stephanie S.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2025, 32 (02): : 121 - 127
  • [32] Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study
    Zhang, Hang
    Li, Li
    Jia, Lei
    Liu, Jinchun
    MEDICINE, 2023, 102 (51) : E36658
  • [33] The relationship of plasma Trans fatty acids with dietary inflammatory index among US adults
    Mazidi, Mohsen
    Gao, Hong-kai
    Shivappa, Nitin
    Wirth, Michael D.
    Hebert, James R.
    Kengne, Andre Pascal
    LIPIDS IN HEALTH AND DISEASE, 2017, 16
  • [34] Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
    Samadarshi, Samir
    Kumar, Dharmendra
    Manrai, Manish
    Dawra, Saurabh
    Srivastava, Sharad
    Chandra, Alok
    JOURNAL OF MARINE MEDICAL SOCIETY, 2025, 27 (01) : 54 - 58
  • [35] A healthy lifestyle is prospectively associated with lower onset of metabolic dysfunction-associated steatotic liver disease
    Grinshpan, Laura S.
    Haim, Yaara Even
    Ivancovsky-Wajcman, Dana
    Fliss-Isakov, Naomi
    Nov, Yuval
    Webb, Muriel
    Shibolet, Oren
    Kariv, Revital
    Zelber-Sagi, Shira
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
  • [36] Predictors of Atherosclerotic Cardiovascular Disease Events in Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
    Kawanaka, Miwa
    Nishino, Ken
    Kawada, Mayuko
    Ishii, Katsunori
    Tanikawa, Tomohiro
    Urata, Noriiyo
    Suehiro, Mitsuhiko
    Haruma, Ken
    Kawamoto, Hirofumi
    INTERNAL MEDICINE, 2024,
  • [37] A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease
    Ramos, Maria Jimenez
    Kendall, Timothy J.
    Drozdov, Ignat
    Fallowfield, Jonathan A.
    ANNALS OF HEPATOLOGY, 2024, 29 (02)
  • [38] A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Castera, Laurent
    Alazawi, William
    Bugianesi, Elisabetta
    Caussy, Cyrielle
    Federici, Massimo
    Romero-Gomez, Manuel
    Schattenberg, Joern M.
    Basuroy, Ron
    Prasad, Preethy
    Estulin, Dmitry
    Lazarus, Jeffrey V.
    LIVER INTERNATIONAL, 2025, 45 (02)
  • [39] FIB-4 Index and Liver Stiffness Measurement are Potential Predictors of Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Kubotsu, Yoshihito
    Sakamoto, Yoshiko
    Tago, Motoko
    Chihara, Atsuko
    Norita, Misa
    Inadomi, Chika
    Inoue, Kaori
    Takayanagi, Hiroki
    Tanaka, Kenichi
    Isoda, Hiroshi
    Kuwashiro, Takuya
    Oeda, Satoshi
    Shiratori, Toshiyasu
    Anzai, Keizo
    Node, Koichi
    Takahashi, Hirokazu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025, 32 (02) : 239 - 252
  • [40] New insights into metabolic dysfunction-associated steatotic liver disease and oxidative balance score
    Peng, Lei
    Li, Lurong
    Liu, Jiahao
    Li, Yuanyuan
    FRONTIERS IN NUTRITION, 2024, 10